Show simple item record

dc.contributor.authorMartin, Bjorn
dc.contributor.authorWehmeyer, Alexander
dc.contributor.authorUpton, Edward
dc.date.accessioned2019-08-05T11:41:28Z
dc.date.available2019-08-05T11:41:28Z
dc.date.issued2018
dc.identifier.citationMartin, B., Wehmeyer, A., & Upton, E. T. (2018). Allergic rhinitis: To sneeze or to wheeze. Pollen is the question, what is the answer? South African Pharmaceutical Journal, 85(5), 37-42.en_US
dc.identifier.issn2220-1017
dc.identifier.urihttps://hdl.handle.net/10520/EJC-11deb013ee
dc.identifier.urihttp://hdl.handle.net/10566/4768
dc.description.abstractAllergic rhinitis, also known colloquially as hay fever, is the most common among the allergic diseases. Recent literature reports that it affects up to a tenth of the world population. Atopic diseases have a particularly high prevalence in young children which is often attributed to their immature immune systems. Traditionally, atopic diseases have plagued industrialised countries, but the burden has recently extended its reach to developing countries. Over the past few decades, there has been a marked increase in all allergy-related diseases. Supported by the advent of the Atopic March, research has been primarily directed at understanding the aetiology and pathophysiology associated with diseases stemming from atopy. In this article, we review current treatments available in South Africa and explain the pathophysiology of allergic rhinitis.en_US
dc.language.isoenen_US
dc.publisherMedpharm Publicationsen_US
dc.subjectAllergic rhinitisen_US
dc.subjectHay feveren_US
dc.subjectAllergiesen_US
dc.subjectAtopic diseasesen_US
dc.subjectTreatmenten_US
dc.titleAllergic rhinitis: To sneeze or to wheeze. Pollen is the question, what is the answer?en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record